Pieris Pharmaceuticals, Inc.
Top 10 Superinvestors by Shares Owned
This chart shows the top 10 superinvestors based on the number of shares they owned in 2024-Q2 and 2024-Q3. According to the most recent SEC 13F filing, 25 superinvestors own shares of Pieris Pharmaceuticals, Inc. (PIRS), although recent data may remain incomplete due to pending filings.
Quarter-over-Quarter Change (%)
This chart highlights the quarter-over-quarter change (%) in the number of superinvestors holding Pieris Pharmaceuticals, Inc. (PIRS), the total shares they held, and the total reported dollar value. It gives a clear view of whether there is ongoing momentum. The dotted lines at the top and bottom adjust longer bars to keep smaller data points visible for better comparison.
Superinvestors' Activity (%) Over the Last 4 Quarters
This chart shows superinvestors' activity with Pieris Pharmaceuticals, Inc. (PIRS) over the last four quarters, highlighting the percentage of investors who added, increased, decreased, held, or exited their positions, revealing shifts in sentiment over time.
Superinvestors' Past Actions
This chart displays superinvestors' past actions with Pieris Pharmaceuticals, Inc. (PIRS) over the last 10 years (40 quarters), helping to visualize the collective momentum and investment trends over time.
Superinvestors ownership
| Superinvestor | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
Weston Nichols@Lynx1 Capital Management Lp
| 0.22% | $620,689 37,436 shares@ 16.59 avg price | Decreased -13.93% |
Alison Peabody@Acadian Asset Management Llc
| 0.01% | $49,000 3,013 shares@ 16.27 avg price | Decreased -72.17% |
Andrew Johnson@Ubs Group Ag
| 0.01% | $5,770 348 shares@ 16.59 avg price | Decreased -79.83% |
Chad Grosam@Group One Trading Llc
| 0.01% | $5,223 312 shares@ 16.75 avg price | Decreased -3.4% |
Daniel Kinsella@Us Bancorp De
| 0.01% | $2,288 138 shares@ 16.58 avg price | Decreased -12.65% |
Michael T. Lees@Jpmorgan Chase & Co
| 0.01% | $870 52 shares@ 16.74 avg price | Decreased -3.7% |